90 related articles for article (PubMed ID: 25867373)
1. Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus.
Feng JK; Lu YF; Li J; Qi YH; Yi ML; Ma DY
Genet Mol Res; 2015 Mar; 14(1):2268-74. PubMed ID: 25867373
[TBL] [Abstract][Full Text] [Related]
2. Association of salivary alpha 2-macroglobulin levels and clinical characteristics in type 2 diabetes.
Chung TJ; Hsu KY; Chen JH; Liu JS; Chang HW; Li PF; Huang CL; Shieh YS; Lee CH
J Diabetes Investig; 2016 Mar; 7(2):190-6. PubMed ID: 27042270
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
4. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
5. Impact of glycemic control on oral health status in type 2 diabetes individuals and its association with salivary and plasma levels of chromogranin A.
Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
Arch Oral Biol; 2016 Feb; 62():10-9. PubMed ID: 26605682
[TBL] [Abstract][Full Text] [Related]
6. Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A.
Kogawa EM; Grisi DC; Falcão DP; Amorim IA; Rezende TM; da Silva IC; Silva ON; Franco OL; de Amorim RF
Clin Oral Investig; 2016 Nov; 20(8):2083-2095. PubMed ID: 26750135
[TBL] [Abstract][Full Text] [Related]
7. Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus.
Yueh CY; Chen JH; Lee LW; Lu CW; Parekh B; Chi CC
Diabetes Res Clin Pract; 2011 Oct; 94(1):64-70. PubMed ID: 21715038
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
9. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Parotid Salivary Glucose Level for Clinical Diagnosis and Monitoring Type 2 Diabetes Mellitus Patients.
Wang B; Du J; Zhu Z; Ma Z; Wang S; Shan Z
Biomed Res Int; 2017; 2017():2569707. PubMed ID: 28251153
[No Abstract] [Full Text] [Related]
11. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus.
Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
Acta Diabetol; 2010 Sep; 47(3):265-70. PubMed ID: 20509034
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of type 2 diabetes mellitus and impaired fasting glucose in semi-urban population of Nepal.
Ono K; Limbu YR; Rai SK; Kurokawa M; Yanagida J; Rai G; Gurung N; Sharma M; Rai CK
Nepal Med Coll J; 2007 Sep; 9(3):154-6. PubMed ID: 18092429
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
[TBL] [Abstract][Full Text] [Related]
14. Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: a study using the National Healthcare Group Diabetes Registry in Singapore.
Ang YG; WU CX; Toh MP; Chia KS; Heng BH
J Diabetes; 2012 Jun; 4(2):159-63. PubMed ID: 22059651
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study on oral candidal infection in individuals with diabetes mellitus and impaired glucose regulation].
Huang JH; Liu Y; Liu HW
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jun; 47(6):335-9. PubMed ID: 22932482
[TBL] [Abstract][Full Text] [Related]
16. Salivary glucose as a metabolic control marker in patients with type 2 diabetes.
Carramolino-Cuéllar E; Lauritano D; Carinci F; Silvestre-Rangil J; Bañuls-Morant C; Silvestre FJ; Hernández-Mijares A
J Biol Regul Homeost Agents; 2017; 31(2 Suppl 1):181-187. PubMed ID: 28691471
[TBL] [Abstract][Full Text] [Related]
17. Molecular form and concentration of serum α
Yoshino S; Fujimoto K; Takada T; Kawamura S; Ogawa J; Kamata Y; Kodera Y; Shichiri M
Sci Rep; 2019 Sep; 9(1):12927. PubMed ID: 31506491
[TBL] [Abstract][Full Text] [Related]
18. Effect of psychological stress on glucose control in patients with Type 2 diabetes.
Faulenbach M; Uthoff H; Schwegler K; Spinas GA; Schmid C; Wiesli P
Diabet Med; 2012 Jan; 29(1):128-31. PubMed ID: 21883440
[TBL] [Abstract][Full Text] [Related]
19. Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
Sazonov V; Maccubbin D; Sisk CM; Canner PL
Int J Clin Pract; 2013 Apr; 67(4):297-302. PubMed ID: 23521322
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of salivary glucose, amylase, and total protein in Type 2 diabetes mellitus patients.
Indira M; Chandrashekar P; Kattappagari KK; Chandra LP; Chitturi RT; Bv RR
Indian J Dent Res; 2015; 26(3):271-5. PubMed ID: 26275194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
